Navidea Biopharma (NAVB) Announces Changes to Board of Directors Composition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Navidea Biopharmaceuticals Announces Changes to Board of Directors Composition
May 5, 2021 8:00 AM EDTIndustry veteran Amit Bhalla appointed to the Board of Directors
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (Navidea or the Company), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that Michael Rice, the Companys Chair of the Board, and Adam Cutler have retired from their positions on Navideas Board of Directors to focus on other endeavors. Dr. Kathy Rouan has been appointed as Chair of the Board following Mr. Rices retirement.
Additionally, Amit Bhalla has been appointed to... More
